PTC Therapeutics Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 1187.34, 1356.17, 1643.75, 1738.72, 1887.11 ], "ebit_estimate": [ 267.13, 403.66, 624.28, 668.87, 793.42 ], "ebitda_estimate": [ 307.26, 462.3, 618.68, null, null ], "net_income_estimate": [ 110.65, 246.36, 395.43, 383.11, 499.44 ], "per_share_eps_estimate": [ 0.39, 1.26, 4.38, 4.22, 5.28 ], "eps_nri_estimate": [ 0.81, 1.84, 2.76, 4.36, 5.28 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 1.66, 5.38, 14.33, null, null ], "pretax_income_estimate": [ 57.59, 232.73, 396.23, 413.08, 541.77 ], "operating_cash_flow_per_share_estimate": [ 2, 3.25, null, null, null ], "roa_estimate": [ 4.4, 6.3, null, null, null ], "roe_estimate": [ 317.1, 118.27, 78.48, null, null ], "gross_margin_estimate": [ 88.4, 83.4, null, null, null ], "operating_cash_flow_estimate": [ 164.63, 267.78, null, null, null ], "pettm_estimate": [ 217.01, 67.5, 19.37, 20.11, 16.06 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -78.84, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 293.06, 293.8, 309.8, 275.18, 291.1, 314.57, 330.97 ], "ebit_estimate": [ 64.34, 68.85, 67.56, 40.91, 51.98, 83.11, 77.78 ], "ebitda_estimate": [ 57.3, 80.31, 76.25, 53.39, null, null, null ], "net_income_estimate": [ 20.96, 16.77, 16.77, 7.6, 4.3, 23.15, 25.45 ], "per_share_eps_estimate": [ 0.12, 0.15, 0.08, -0.13, -0.17, 0.06, -0.06 ], "eps_nri_estimate": [ 0.32, 0.25, 0.22, 0.03, 0, 0.28, 0.2 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ -5.27, -5.52, -5.26, null, null, null, null ], "pretax_income_estimate": [ 11.04, 11.88, 12.72, -14.93, -10.19, 13.15, 8.17 ], "operating_cash_flow_per_share_estimate": [ 5.92, 9.17, null, null, null, null, null ], "roa_estimate": [ -3, -2.6, -1.9, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 90, 90, 90, 89, 89, 89, 89 ], "operating_cash_flow_estimate": [ 488.52, 756.72, null, null, null, null, null ], "pettm_estimate": [ 385.68, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -78.84, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }